The IMLFF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IMLFF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The IMLFF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View IMLFF Detailed Price Forecast - CNN Money||View IMLFF Detailed Summary - Google Finance|
|View IMLFF Detailed Summary - Yahoo! Finance||View IMLFF Stock Research & Analysis - Zacks.com|
|View IMLFF Trends & Analysis - Trade-Ideas||View IMLFF Major Holders - Barrons|
|View IMLFF Call Transcripts - NASDAQ||View IMLFF Breaking News & Analysis - Seeking Alpha|
|View IMLFF Annual Report - CompanySpotlight.com||View IMLFF OTC Short Report - OTCShortReport.com|
|View IMLFF Fundamentals - TradeKing||View IMLFF SEC Filings - Bar Chart|
|View Historical Prices for IMLFF - The WSJ||View Performance/Total Return for IMLFF - Morningstar|
|View the Analyst Estimates for IMLFF - MarketWatch||View the Earnings History for IMLFF - CNBC|
|View the IMLFF Earnings - StockMarketWatch||View IMLFF Buy or Sell Recommendations - MacroAxis|
|View the IMLFF Bullish Patterns - American Bulls||View IMLFF Short Pain Metrics - ShortPainBot.com|
|View IMLFF Stock Mentions - StockTwits||View IMLFF Stock Mentions - PennyStockTweets|
|View IMLFF Stock Mentions - Twitter||View IMLFF Investment Forum News - Investor Hub|
|View IMLFF Stock Mentions - Yahoo! Message Board||View IMLFF Stock Mentions - Seeking Alpha|
|View Insider Transactions for IMLFF - SECform4.com||View Insider Transactions for IMLFF - Insider Cow|
|View IMLFF Major Holdings Summary - CNBC||View Insider Disclosure for IMLFF - OTC Markets|
|View Insider Transactions for IMLFF - Yahoo! Finance||View Institutional Holdings for IMLFF - NASDAQ|
|View IMLFF Stock Insight & Charts - FinViz.com||View IMLFF Investment Charts - StockCharts.com|
|View IMLFF Stock Overview & Charts - BarChart||View IMLFF User Generated Charts - Trading View|
InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
Posted on Friday January 11, 2019
OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today announced that Dr. Sazzad Hossain, PhD, MSc, will assume a position as member of the Scientific Advisory Board ("SAB") and, contemporaneously, announced his retirement as Chief Scientific Officer ("CSO"). Dr. Eric C. Hsu, PhD, Vice President, Pre-Clinical Research & Development, will continue to lead the scientific R&D programs of the Company.
InMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019
Posted on Thursday January 03, 2019
VANCOUVER , Jan. 3, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (IN.TO) (IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, will be presenting at the Biotech Showcase 2019 on Wednesday, January 9, 2019 , at 9:00 AM PT / 12:00 PM ET at the Hilton San Francisco Union Square, in San Francisco, California . A live audio webcast of the presentation will be available through InMed's corporate website in the 'Investor' section at https://investors.inmedpharma.com. InMed is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.
InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program
Posted on Tuesday December 04, 2018
OTCQX:IMLFF), a cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, is pleased to announce that it has signed a contribution agreement with the National Research Council Canada Industrial Research Assistance Program ("NRC IRAP") to receive funding of up to C$500,000 to support InMed's ongoing R&D efforts in cannabinoid biosynthesis. NRC IRAP provides advisory services and funding to Canadian businesses to promote accelerated growth and technology innovation.
InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
Posted on Monday November 12, 2018
TSX:IN OTCQX:IMLFF VANCOUVER , Nov. 12, 2018 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical ...